These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34482614)
1. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses. Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614 [TBL] [Abstract][Full Text] [Related]
2. The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System. Ahn DJ; Zeng S; Pelzer KM; Barth RN; Gallo A; Parker WF Transplantation; 2023 Oct; 107(10):e247-e256. PubMed ID: 37408100 [TBL] [Abstract][Full Text] [Related]
3. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284 [TBL] [Abstract][Full Text] [Related]
4. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation. Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689 [TBL] [Abstract][Full Text] [Related]
5. Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy. Ishaque T; Beckett J; Gentry S; Garonzik-Wang J; Karhadkar S; Lonze BE; Halazun KJ; Segev D; Massie AB Transplantation; 2024 Aug; 108(8):e170-e180. PubMed ID: 38548691 [TBL] [Abstract][Full Text] [Related]
6. Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States. Shah RH; Chyou D; Goldberg DS Liver Transpl; 2022 Dec; 28(12):1857-1864. PubMed ID: 35585774 [TBL] [Abstract][Full Text] [Related]
9. HCC patients suffer less from geographic differences in organ availability. Schuetz C; Dong N; Smoot E; Elias N; Schoenfeld DA; Markmann JF; Yeh H Am J Transplant; 2013 Nov; 13(11):2989-95. PubMed ID: 24011291 [TBL] [Abstract][Full Text] [Related]
10. Impact of Median MELD at Transplant Minus 3 National Policy on Quality of Transplanted Livers for Patients With and Without Hepatocellular Carcinoma. Mazur RD; Cron DC; Chang DC; Yeh H; Dageforde LAD Transplantation; 2024 Jan; 108(1):204-214. PubMed ID: 37189232 [TBL] [Abstract][Full Text] [Related]
11. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U; J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates. Chang CH; Bryce CL; Shneider BL; Yabes JG; Ren Y; Zenarosa GL; Tomko H; Donnell DM; Squires RH; Roberts MS JAMA Pediatr; 2018 Nov; 172(11):1070-1077. PubMed ID: 30242345 [TBL] [Abstract][Full Text] [Related]
13. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil. Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144 [TBL] [Abstract][Full Text] [Related]
14. Liver and intestine transplantation in the United States 1998-2007. Berg CL; Steffick DE; Edwards EB; Heimbach JK; Magee JC; Washburn WK; Mazariegos GV Am J Transplant; 2009 Apr; 9(4 Pt 2):907-31. PubMed ID: 19341415 [TBL] [Abstract][Full Text] [Related]
15. Waitlist mortality and post-liver transplant outcomes of pediatric patients with hepatocellular carcinoma and hepatoblastoma in the United States. Wu WK; Ziogas IA; Matsuoka LK; Izzy M; Pai AK; Benedetti DJ; Alexopoulos SP Pediatr Blood Cancer; 2022 Jan; 69(1):e29425. PubMed ID: 34736292 [TBL] [Abstract][Full Text] [Related]